Sotera Health (SHC)
(Delayed Data from NSDQ)
$16.13 USD
-0.67 (-3.99%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $16.13 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Sotera Health Company falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 51.38 | -233.57 | 117.12 | -37.49 | -20.43 |
Depreciation/Amortization & Depletion | 166.98 | 160.85 | 157.06 | 155.19 | 155.01 |
Net Change from Assets/Liabilities | -403.29 | 409.23 | -12.59 | -11.79 | -8.35 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 37.20 | -58.55 | 19.95 | 14.68 | 22.81 |
Net Cash From Operating Activities | -147.73 | 277.96 | 281.55 | 120.59 | 149.04 |
Property & Equipment | -214.98 | -182.38 | -102.16 | -53.51 | -57.26 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.07 | 0.48 | -57.67 | -105.19 | 0.00 |
Net Cash from Investing Activities | -214.91 | -181.90 | -159.83 | -158.69 | -57.26 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | -8.42 | 1,121.96 | 0.00 |
Issuance (Repayment) of Debt | 297.50 | 200.00 | -100.00 | -1,027.33 | 583.52 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | -691.17 |
Other Financing Activities | -31.54 | -2.24 | -8.87 | -21.20 | -18.38 |
Net Cash from Financing Activities | 265.96 | 197.76 | -117.29 | 73.43 | -126.03 |
Effect of Exchange Rate Changes | 2.04 | -4.46 | 0.04 | 4.11 | 0.49 |
Net Change In Cash & Equivalents | -94.64 | 289.37 | 4.47 | 39.43 | -33.76 |
Cash at Beginning of Period | 396.29 | 106.92 | 102.45 | 63.03 | 96.79 |
Cash at End of Period | 301.65 | 396.29 | 106.92 | 102.45 | 63.03 |
Diluted Net EPS | 0.18 | -0.83 | 0.41 | -0.16 | -0.09 |
Fiscal Year End for Sotera Health Company falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 15.08 | 6.32 | 51.38 | 12.70 | 26.36 |
Depreciation/Amortization & Depletion | 84.96 | 42.97 | 166.98 | 123.73 | 83.14 |
Net Change from Assets/Liabilities | -56.67 | -41.23 | -403.29 | -426.32 | -430.53 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 27.63 | 1.64 | 37.20 | 29.04 | 18.33 |
Net Cash From Operating Activities | 70.99 | 9.70 | -147.73 | -260.86 | -302.70 |
Property & Equipment | -76.81 | -34.89 | -214.98 | -150.15 | -98.13 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.04 | 0.04 | 0.07 | 0.07 | 0.03 |
Net Cash from Investing Activities | -76.77 | -34.85 | -214.91 | -150.08 | -98.10 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -1.25 | -1.25 | 297.50 | 298.75 | 300.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -40.11 | -10.69 | -31.54 | -29.00 | -26.79 |
Net Cash from Financing Activities | -41.36 | -11.94 | 265.96 | 269.75 | 273.21 |
Effect of Exchange Rate Changes | -6.75 | -1.74 | 2.04 | -2.58 | 1.80 |
Net Change In Cash & Equivalents | -53.90 | -38.83 | -94.64 | -143.76 | -125.80 |
Cash at Beginning of Period | 301.65 | 301.65 | 396.29 | 396.29 | 396.29 |
Cash at End of Period | 247.76 | 262.82 | 301.65 | 252.53 | 270.49 |
Diluted Net EPS | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 |